Literature DB >> 14117453

ANTIBODIES IN SYSTEMIC LUPUS ERYTHEMATOSUS AND MYASTHENIA GRAVIS WHICH REACT WITH THERMALLY DENATURED DNA-COATED BENTONITE.

B C STURGILL, R R CARPENTER, A J STRAUSS, H C GOODMAN.   

Abstract

Entities:  

Keywords:  ALUMINUM SILICATES; ANTIBODIES; ANTIGEN-ANTIBODY REACTIONS; ARTHRITIS, RHEUMATOID; DNA; LUPUS ERYTHEMATOSUS, SYSTEMIC; MUSCULAR DISEASES; MYASTHENIA GRAVIS; RHEUMATOID FACTOR; SCLERODERMA; SJOGREN'S SYNDROME

Mesh：

Substances：

Year:  1964        PMID： 14117453     DOI： 10.3181/00379727-115-28882

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  7 in total

1.  Immunological detection of nucleic acids and antibodies to nucleic acids and nuclear antigens by counterimmunoelectrophoresis.

Authors:  P H Schur; D DeAngelis; J M Jackson
Journal:  Clin Exp Immunol       Date:  1974-05       Impact factor: 4.330

Review 2.  [The pathogenesis of myasthenia gravis as an immunological problem].

Authors:  J R Kalden
Journal:  Klin Wochenschr       Date:  1970-01-01

3.  The relation of immunoglobulin class, pattern of anti-nuclear antibody, and complement-fixing antibodies to DNA in sera from patients with systemic lupus erythematosus.

Authors:  N F Rothfield; B D Stollar
Journal:  J Clin Invest       Date:  1967-11       Impact factor: 14.808

4.  An ultrastructural study of spontaneous lupus nephritis in the NZB-BL-NZW mouse.

Authors:  A A Channing; T Kasuga; R E Horowitz; E L Dubois; H B Demopoulos
Journal:  Am J Pathol       Date:  1965-10       Impact factor: 4.307

5.  Drosophila salivary chromosomes as test system for antinuclear antibody assay.

Authors:  J C Herr; J R Ellison
Journal:  Clin Exp Immunol       Date:  1973-11       Impact factor: 4.330

6.  Lymphocyte transformation in thymectomized and nonthymectomized patients with myasthenia gravis.

Authors:  J Houseley; J J Oppenheim
Journal:  Br Med J       Date:  1967-06-10

7.  ANTI-DNA ANTIBODIES IN HYPERIMMUNIZED RABBITS.

Authors:  C L CHRISTIAN; A R DESIMONE; J L ABRUZZO
Journal:  J Exp Med       Date:  1965-02-01       Impact factor: 14.307
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.